| Product Name | MF | CAS | Details |
|---|
| 3-(1，3-dioxolan-2-yl)phenol | C9H10O3 | 7070-85-1 | Details |
| 1，3-Dichloro-2-Methylpropane | C4H8Cl2 | 616-19-3 | Details |
| 1-Phenylpropane-1，2-Diol | C9H12O2 | 1855-09-0 | Details |
| Sulfamic Acid Methyl Ester | CH5NO3S | 55665-95-7 | Details |
| 1，2-bis(4，5-dihydrothiazol-2-yl)disulfane | C6H8N2S4 | 2801-13-0 | Details |
| 3-hydroxypiperidine-2-carboxylic acid | C6H11NO3 | 56879-47-1 | Details |
| TD-106（3-(5-amino-4-oxobenzo[d][1,2,3]triazin-3(4H)-yl)piperidine-2,6-dione） | C12H11N5O3 | 2250288-69-6 | Details |
| Thalidomide-NH-CH2-COO(t-Bu) | C19H21N3O6 | 2093386-23-1 | Details |
| Thalidomide-NH-(CH2)2-NH-Boc | C20H24N4O6 | 1957235-57-2 | Details |
| Thalidomide-NH-(CH2)2-NH2 TFA | C17H17F3N4O6 | 1957235-67-4 | Details |
| Thalidomide-NH-(CH2)3-NH-Boc | C21H26N4O6 | 2093386-36-6 | Details |
| Thalidomide-5-NH-CH2-COO(t-Bu) | C19H21N3O6 | 2412056-28-9 | Details |
| Thalidomide-5-O-CH2-COO(t-Bu) | C19H20N2O7 | 2682112-10-1 | Details |
| Thalidomide-5-O-CH2-COOH | C15H12N2O7 | 2467425-53-0 | Details |
| Thalidomide-4-propargyl | C16H12N2O5 | 2098487-39-7 | Details |
| Thalidomide-4-NH-PEG1-NH-Boc | C22H28N4O7 | 2154342-17-1 | Details |
| Thalidomide-4-NH-PEG1-COO(t-Bu) | C22H27N3O7 | 2140807-19-6 | Details |
| Thalidomide-4-NH-PEG2-COO(t-Bu) | C24H31N3O8 | 2140807-16-3 | Details |
| VH032-NH-CO-CH2-Br | C24H31BrN4O4S | 2379404-33-6 | Details |
| VH032-NH-CO-CH2-NHBoc | C29H41N5O6S | 2010986-19-1 | Details |
| VH032-NH-CO-CH2-NH2 | C24H33N5O4S | 2010986-20-4 | Details |
| INDEX NAME NOT YET ASSIGNED | C23H30N4O5S | 2111829-84-4 | Details |
| L-Prolinamide, N-[(1,1-dimethylethoxy)carbonyl]-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- | C26H36N4O5S | 1448189-66-9 | Details |
| L-Prolinamide, N-[4-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxobutyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- | C31H45N5O6S | 2361119-87-9 | Details |
| INDEX NAME NOT YET ASSIGNED | C30H42N4O6S | 2827750-24-1 | Details |
| (Z)-Methyl 3-Aminobut-2-Enoate | C5H9NO2 | 21731-17-9 | Details |
| Ethyl (Z)-3-Aminobut-2-Enoate | C6H11NO2 | 626-34-6 | Details |
| Ethyl (E)-3-Ethoxybut-2-Enoate | C8H14O3 | 57592-45-7 | Details |
| 1-(pyridin-4-yl)urea | C6H7N3O | 13262-38-9 | Details |
| 1,3-di(pyridin-4-yl)urea | C11H10N4O | 39642-87-0 | Details |
| picolinoyl chloride | C6H4ClNO | 29745-44-6 | Details |
| 3-oxobutanal | C4H6O2 | 625-34-3 | Details |
| Cholesta-3,5-dien-7-one | C27H42O | 567-72-6 | Details |
| Aprepitant Impurity 2 | C20H19ClF7NO2 | 171482-05-6 | Details |
| Cefditoren sodium | C19H19N6NaO5S3 | 104146-53-4 | Details |
| Chlorphenamine EP Impurity C | C15H17ClN2 | 20619-12-9 | Details |
| Vancomycin EP Impurity D | C59H62Cl2N8O22 | 101485-50-1 | Details |
| Vancomycin EP Impurity A | C65H73Cl2N9O24 | 91700-98-0 | Details |
| Terbutaline EP Impurity D | C19H23NO3 | 94109-61-2 | Details |
| Trifluridine Impurity 4 | 362607-81-6 | Details |
| Terazosin EP Impurity N | C9H16N2O2 | 63074-07-7 | Details |
| Terazosin EP Impurity M | C14H14N2O4 | 31350-27-3 | Details |
| Sugammadex sodium Org199129-1 Impurity | 2412953-06-9 | Details |
| Rapamycin impurity 5 | C51H79NO15 | 500733-49-3 | Details |
| 28-epi-Rapamycin | C51H79NO13 | 253431-35-5 | Details |
| Pitavastatin Impurity 3 | C37H30BrFNP | 154057-58-6 | Details |
| Oxymetazoline EP Impurity B | C16H24N2 | 526-36-3 | Details |
| Norfloxacin EP Impurity H | C19H22FN3O5 | 105440-01-5 | Details |
| Medetomidine Impurity 20 | C10H13Cl | 104245-83-2 | Details |
| Medetomidine Impurity 8 | C13H17ClN2 | 190000-46-5 | Details |
| Moxifloxacin impurity 26 | C14H20N2 | 161594-54-3 | Details |
| Avatrombopag impurity 43 | C14H17ClN2O4 | 931395-73-2 | Details |
| Avatrombopag impurity 35 | C23H24Cl3N5OS2 | 570403-04-2 | Details |
| Avatrombopag impurity 34 | C6H2Cl3NO | 54127-29-6 | Details |
| Avatrombopag impurity 26 | C7H4BrClN2S2 | 2161380-87-4 | Details |
| Avatrombopag impurity 8 | C6H4BrClOS | 677007-73-7 | Details |
| Avatrombopag impurity 5 | C7H5ClN2S2 | 123971-45-9 | Details |
| Rosuvastatin Impurity 9 | C15H26O6 | 2375865-91-9 | Details |
| Latamoxef impurity 9 | C9H8O5 | 64076-52-4 | Details |
| Levetiracetam EP Impurity C | C5H5NO | 142-08-5 | Details |
| Levetiracetam Impurity 8 | C4H6Cl2O | 4635-59-0 | Details |
| Levocetirizine Impurity 1 | C21H26ClN3O2 | 909779-33-5 | Details |
| (S)-Cetirizine | C21H25ClN2O3 | 130018-76-7 | Details |
| Levocetirizine Impurity 11 | C17H19ClN2 | 70558-10-0 | Details |
| Levocetirizine Impurity 12 | C17H19ClN2 | 109036-15-9 | Details |
| Moxifloxacin impurity 3 | C21H25N3O5 | 2445515-66-0 | Details |
| Moxifloxacin impurity 16 | C11H10F3NO2 | 2327019-81-6 | Details |
| Avatrombopag impurity 45 | C19H16Cl2N4O3S2 | 832088-14-9 | Details |
| Atorvastatin EP Impurity K | C34H37FN2O5 | 345891-62-5 | Details |
| Gemcitabine impurity 10 | C10H16F2O5 | 928797-50-6 | Details |
| Gemcitabine impurity 9 | C19H14F2O6 | 122111-02-8 | Details |
| Gemcitabine impurity 8 | C16H15F2N3O5 | 2174019-90-8 | Details |
| Gemcitabine impurity 6 | C20H18F2O8S | 134877-43-3 | Details |
| Gemcitabine impurity 5 | C19H18F2O6 | 1258595-49-1 | Details |
| Gemcitabine EP Impurity B HCl | C9H12ClF2N3O4 | 122111-05-1 | Details |
| Gemcitabine EP Impurity B | C9H11F2N3O4 | 95058-85-8 | Details |
| Formoterol Impurity 1 | C15H14BrNO4 | 188690-82-6 | Details |
| Fusidic Acid EP Impurity J（ Sodium Fusidate EP Impurity J） | C29H44O4 | 13011-12-6 | Details |
| Fosaprepitant impurity 8 | C23H22F7N4O6P | 1523569-89-2 | Details |
| Fosaprepitant impurity 7 | C23H22F7N4O6P | 172822-01-4 | Details |
| Fosaprepitant impurity 6 | C23H22F7N4O6P | 2514928-37-9 | Details |
| Fosaprepitant impurity 5 | C23H22F7N4O6P | 1185503-00-7 | Details |
| Fosaprepitant impurity 4 | C23H22F7N4O6P | 1523569-86-9 | Details |
| Fosaprepitant impurity 3 | C37H34F7N4O6P | 265121-01-5 | Details |
| Edoxaban impurity 13 | C9H10Cl2N2O3 | 1243308-37-3 | Details |
| Dexrazoxane impurity 12 | C11H18N4O5 | 120418-76-0 | Details |
| Dexrazoxane impurity 8 | C13H16N6O3 | 2084092-84-0 | Details |
| Bromoacetaldehyde | C2H3BrO | 17157-48-1 | Details |
| Dexrazoxane impurity 7 | C13H16N6O3 | 2084092-82-8 | Details |
| Fusidic Acid EP Impurity O（ Sodium Fusidate EP Impurity O） | C29H46O5 | 13090-91-0 | Details |
| Gadobutrol Impurity 7 | C9H16N4 | 54364-78-2 | Details |
| Gemcitabine impurity 4 | C19H16F2O7 | 866473-31-6 | Details |
| Vancomycin Impurity 1 | C66H74Cl2N10O25 | 155386-25-7 | Details |
| Latamoxef impurity 13 | C14H12O3 | 65664-73-5 | Details |
| Betahistine Impurity 4 | C9H13NO3 | 37445-98-0 | Details |
| INDEX NAME NOT YET ASSIGNED | C32H46N4O6S | 2827750-25-2 | Details |
| L-Prolinamide, N-(12,12-dimethyl-1,10-dioxo-3,6,11-trioxa-9-azatridec-1-yl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- | C33H49N5O8S | 2162120-75-2 | Details |
| L-Prolinamide, N-[2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethoxy]acetyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- | C31H45N5O7S | 2409007-41-4 | Details |
| L-Prolinamide, N-[8-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxooctyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- | C35H53N5O6S | 2306389-02-4 | Details |
| L-Prolinamide, N-[6-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxohexyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- | C33H49N5O6S | 2412055-00-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 | ||||